MedPath

Bagoxed

Brand Name: Bagoxed

Generic Name: Pemetrexed (As Disodium Hemipentahydrate)

Active
Registration Number

DR-XY45722

Dosage Form

Lyophilized Powder For Infusion (Iv)

Issuance Date

February 2, 2023

Expiry Date

March 6, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg
PackagingUSP Type I Clear and colorless glass vial (Box of 1 vial)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial (from Monitored Release)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Pemetrexed (As Disodium Hemipentahydrate)Active
Monograph: pemetrexed (as disodium hemipentahydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform